MindWalk Holdings (HYFT) Other financing activities (2020 - 2025)
MindWalk Holdings (HYFT) reported Other financing activities of -$227069.0 for Q3 2025, down 206.48% year-over-year from $213251.1 in Q3 2024, and down 202.91% quarter-over-quarter from $220656.8 in Q2 2025.
MindWalk Holdings (HYFT) Other financing activities (2020 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has 6 years of Other financing activities data on file, last reported at -$227069.0 in Q3 2025.
- Other financing activities for Q3 2025 came in at -$227069.0, down 206.48% year-over-year; the trailing twelve-month figure through Apr 2025 was $220656.8 (up 5.35% YoY), and the FY2025 annual result was $225416.6, up 7.62% from the prior year.
- Other financing activities declined to -$227069.0 in Q3 2025 per HYFT's latest filing, from $220656.8 in the prior quarter.
- Over five years, Other financing activities peaked at $779804.7 in Q1 2021 and troughed at -$227069.0 in Q3 2025.
- A 5-year average of $309138.4 and a median of $219439.4 in 2024 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2025: Other financing activities soared 47.71% in 2022, then sank 206.48% in 2025.
- A 5-year view of Other financing activities shows it stood at $395560.2 in 2021, then declined by 5.4% to $374189.0 in 2022, then slumped by 42.65% to $214610.7 in 2023, then gained by 1.68% to $218222.0 in 2024, then slumped by 204.05% to -$227069.0 in 2025.
- Business Quant data shows HYFT's Other financing activities at -$227069.0 in Q3 2025, $220656.8 in Q2 2025, and $209919.2 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -227,069.02 |
| Jul 31, 2025 | -227,069.02 |
| Apr 30, 2025 | 220,656.81 |
| Apr 30, 2025 | 220,656.81 |
| Jan 31, 2025 | 209,919.20 |
| Jan 31, 2025 | 209,919.20 |
| Oct 31, 2024 | 218,222.03 |
| Oct 31, 2024 | 218,222.03 |
| Jul 31, 2024 | 213,251.10 |
| Jul 31, 2024 | 213,251.10 |
| Apr 30, 2024 | 209,455.76 |
| Apr 30, 2024 | 209,455.76 |
| Jan 31, 2024 | 213,779.51 |
| Jan 31, 2024 | 213,779.51 |
| Oct 31, 2023 | 214,610.72 |
| Oct 31, 2023 | 214,610.72 |
| Jul 31, 2023 | 213,523.08 |
| Jul 31, 2023 | 213,523.08 |
| Apr 30, 2023 | 324,442.59 |
| Apr 30, 2023 | 324,442.59 |